Conjugate Vaccine Market in South Korea - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 94 pages | ID: C9F2CCCB91D4EN
Market Monitor Global

Abstracts

Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.

This report contains market size and forecasts of Conjugate Vaccine in South Korea, including the following market information:
South Korea Conjugate Vaccine Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Conjugate Vaccine Market Consumption, 2015-2020, 2021-2026, (Million Unit)
South Korea Conjugate Vaccine Production Capacity, 2015-2020, 2021-2026, (Million Unit)
Top Five Competitors in South Korea Conjugate Vaccine Market 2019 (%)
The global Conjugate Vaccine market was valued at 9687.6 million in 2019 and is projected to reach US$ 10930 million by 2026, at a CAGR of 3.1% during the forecast period. While the Conjugate Vaccine market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Conjugate Vaccine manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Conjugate Vaccine production and consumption in South Korea

Total Market by Segment:

South Korea Conjugate Vaccine Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Million Unit)
South Korea Conjugate Vaccine Market Segment Percentages, By Type, 2019 (%)

• Hib Vaccine
• Meningococcal Vaccine
• Pneumococcal Vaccine
• Others

South Korea Conjugate Vaccine Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Million Unit)
South Korea Conjugate Vaccine Market Segment Percentages, By Application, 2019 (%)

• Children
• Adult

Competitor Analysis

The report also provides analysis of leading market participants including:
Total Conjugate Vaccine Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Conjugate Vaccine Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Conjugate Vaccine Market Competitors Sales, by Players 2015-2020 (Estimated), (Million Unit)
Total South Korea Conjugate Vaccine Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

• Pfizer
• GSK
• Sanofi
• Merck
• Walvax Biotechnology
• Royal (Wuxi) Bio-Pharmaceutical
• Bharat Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Conjugate Vaccine Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 South Korea Conjugate Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTH KOREA CONJUGATE VACCINE OVERALL MARKET SIZE

2.1 South Korea Conjugate Vaccine Market Size: 2020 VS 2026
2.2 South Korea Conjugate Vaccine Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Conjugate Vaccine Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Conjugate Vaccine Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Conjugate Vaccine Companies Ranked by Revenue
3.3 South Korea Conjugate Vaccine Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Conjugate Vaccine Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Conjugate Vaccine Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Conjugate Vaccine Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Conjugate Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjugate Vaccine Players in South Korea
  3.8.1 List of South Korea Tier 1 Conjugate Vaccine Companies
  3.8.2 List of South Korea Tier 2 and Tier 3 Conjugate Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - South Korea Conjugate Vaccine Market Size Markets, 2020 & 2026
  4.1.2 Hib Vaccine
  4.1.3 Meningococcal Vaccine
  4.1.4 Pneumococcal Vaccine
  4.1.5 Others
4.2 By Type - South Korea Conjugate Vaccine Revenue & Forecasts
  4.2.1 By Type - South Korea Conjugate Vaccine Revenue, 2015-2020
  4.2.2 By Type - South Korea Conjugate Vaccine Revenue, 2021-2026
  4.2.3 By Type - South Korea Conjugate Vaccine Revenue Market Share, 2015-2026
4.3 By Type - South Korea Conjugate Vaccine Sales & Forecasts
  4.3.1 By Type - South Korea Conjugate Vaccine Sales, 2015-2020
  4.3.2 By Type - South Korea Conjugate Vaccine Sales, 2021-2026
  4.3.3 By Type - South Korea Conjugate Vaccine Sales Market Share, 2015-2026
4.4 By Type - South Korea Conjugate Vaccine Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - South Korea Conjugate Vaccine Market Size, 2020 & 2026
  5.1.2 Children
  5.1.3 Adult
5.2 By Application - South Korea Conjugate Vaccine Revenue & Forecasts
  5.2.1 By Application - South Korea Conjugate Vaccine Revenue, 2015-2020
  5.2.2 By Application - South Korea Conjugate Vaccine Revenue, 2021-2026
  5.2.3 By Application - South Korea Conjugate Vaccine Revenue Market Share, 2015-2026
5.3 By Application - South Korea Conjugate Vaccine Sales & Forecasts
  5.3.1 By Application - South Korea Conjugate Vaccine Sales, 2015-2020
  5.3.2 By Application - South Korea Conjugate Vaccine Sales, 2021-2026
  5.3.3 By Application - South Korea Conjugate Vaccine Sales Market Share, 2015-2026
5.4 By Application - South Korea Conjugate Vaccine Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Pfizer
  6.1.1 Pfizer Corporate Summary
  6.1.2 Pfizer Business Overview
  6.1.3 Pfizer Conjugate Vaccine Major Product Offerings
  6.1.4 Pfizer Sales and Revenue in South Korea (2015-2020)
  6.1.5 Pfizer Key News
6.2 GSK
  6.2.1 GSK Corporate Summary
  6.2.2 GSK Business Overview
  6.2.3 GSK Conjugate Vaccine Major Product Offerings
  6.2.4 GSK Sales and Revenue in South Korea (2015-2020)
  6.2.5 GSK Key News
6.3 Sanofi
  6.3.1 Sanofi Corporate Summary
  6.3.2 Sanofi Business Overview
  6.3.3 Sanofi Conjugate Vaccine Major Product Offerings
  6.3.4 Sanofi Sales and Revenue in South Korea (2015-2020)
  6.3.5 Sanofi Key News
6.4 Merck
  6.4.1 Merck Corporate Summary
  6.4.2 Merck Business Overview
  6.4.3 Merck Conjugate Vaccine Major Product Offerings
  6.4.4 Merck Sales and Revenue in South Korea (2015-2020)
  6.4.5 Merck Key News
6.5 Walvax Biotechnology
  6.5.1 Walvax Biotechnology Corporate Summary
  6.5.2 Walvax Biotechnology Business Overview
  6.5.3 Walvax Biotechnology Conjugate Vaccine Major Product Offerings
  6.5.4 Walvax Biotechnology Sales and Revenue in South Korea (2015-2020)
  6.5.5 Walvax Biotechnology Key News
6.6 Royal (Wuxi) Bio-Pharmaceutical
  6.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
  6.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Major Product Offerings
  6.6.4 Royal (Wuxi) Bio-Pharmaceutical Sales and Revenue in South Korea (2015-2020)
  6.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News
6.7 Bharat Biotech
  6.6.1 Bharat Biotech Corporate Summary
  6.6.2 Bharat Biotech Business Overview
  6.6.3 Bharat Biotech Conjugate Vaccine Major Product Offerings
  6.4.4 Bharat Biotech Sales and Revenue in South Korea (2015-2020)
  6.7.5 Bharat Biotech Key News
6.8 Zhifei Biologic
  6.8.1 Zhifei Biologic Corporate Summary
  6.8.2 Zhifei Biologic Business Overview
  6.8.3 Zhifei Biologic Conjugate Vaccine Major Product Offerings
  6.8.4 Zhifei Biologic Sales and Revenue in South Korea (2015-2020)
  6.8.5 Zhifei Biologic Key News

7 CONJUGATE VACCINE PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Conjugate Vaccine Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
  7.1.1 South Korea Conjugate Vaccine Production Capacity, 2015-2026
  7.1.2 South Korea Conjugate Vaccine Production 2015-2026
  7.1.3 South Korea Conjugate Vaccine Production Value 2015-2026
7.2 Key Local Conjugate Vaccine Manufacturers in South Korea
  7.2.1 South Korea Key Local Conjugate Vaccine Manufacturers Production Capacity
  7.2.2 South Korea Key Local Conjugate Vaccine Manufacturers Production
  7.2.3 South Korea Key Local Conjugate Vaccine Manufacturers Production Value
  7.2.4 The Proportion of Conjugate Vaccine Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Conjugate Vaccine Export and Import in South Korea
  7.3.1 South Korea Conjugate Vaccine Export Market
  7.3.2 South Korea Conjugate Vaccine Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for South Korea Conjugate Vaccine Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON CONJUGATE VACCINE SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Conjugate Vaccine Distributors and Sales Agents in South Korea

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Conjugate Vaccine in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Conjugate Vaccine Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Conjugate Vaccine Revenue Share by Companies, 2015-2020
Table 5. South Korea Conjugate Vaccine Sales by Companies, (Million Unit), 2015-2020
Table 6. South Korea Conjugate Vaccine Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Conjugate Vaccine Price (2015-2020) (USD/Unit)
Table 8. South Korea Manufacturers Conjugate Vaccine Product Type
Table 9. List of South Korea Tier 1 Conjugate Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Conjugate Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Conjugate Vaccine Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Conjugate Vaccine Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Conjugate Vaccine Sales in South Korea (Million Unit), 2015-2020
Table 14. By Type - Conjugate Vaccine Sales in South Korea (Million Unit), 2021-2026
Table 15. By Application - Conjugate Vaccine Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Conjugate Vaccine Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Conjugate Vaccine Sales in South Korea, (Million Unit), 2015-2020
Table 18. By Application - Conjugate Vaccine Sales in South Korea, (Million Unit), 2021-2026
Table 19. Pfizer Corporate Summary
Table 20. Pfizer Conjugate Vaccine Product Offerings
Table 21. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. GSK Corporate Summary
Table 23. GSK Conjugate Vaccine Product Offerings
Table 24. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Sanofi Corporate Summary
Table 26. Sanofi Conjugate Vaccine Product Offerings
Table 27. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Merck Corporate Summary
Table 29. Merck Conjugate Vaccine Product Offerings
Table 30. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Walvax Biotechnology Corporate Summary
Table 32. Walvax Biotechnology Conjugate Vaccine Product Offerings
Table 33. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
Table 35. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Offerings
Table 36. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 37. Bharat Biotech Corporate Summary
Table 38. Bharat Biotech Conjugate Vaccine Product Offerings
Table 39. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 40. Zhifei Biologic Corporate Summary
Table 41. Zhifei Biologic Conjugate Vaccine Product Offerings
Table 42. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 43. Conjugate Vaccine Production Capacity (Million Unit) of Local Manufacturers in South Korea, 2015-2020
Table 44. Conjugate Vaccine Production (Million Unit) of Local Manufacturers in South Korea, 2015-2020
Table 45. South Korea Conjugate Vaccine Production Market Share of Local Manufacturers, 2015-2020
Table 46. Conjugate Vaccine Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 47. South Korea Conjugate Vaccine Production Value Market Share of Local Manufacturers, 2015-2020
Table 48. The Percentage of Conjugate Vaccine Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 49. The Percentage of Conjugate Vaccine Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 50. Dangeguojia Conjugate Vaccine Sales (Consumption), Production, Export and Import, 2015-2020
Table 51. Raw Materials and Suppliers
Table 52. Conjugate Vaccine Downstream Clients in South Korea
Table 53. Conjugate Vaccine Distributors and Sales Agents in South Korea

List Of Figures

LIST OF FIGURES

Figure 1. Conjugate Vaccine Segment by Type
Figure 2. Conjugate Vaccine Segment by Application
Figure 3. Dangeguojia Conjugate Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Conjugate Vaccine Market Size in South Korea, (US$, Mn) & (Million Unit): 2020 VS 2026
Figure 6. South Korea Conjugate Vaccine Revenue, 2015-2026 (US$, Mn)
Figure 7. Conjugate Vaccine Sales in South Korea: 2015-2026 (Million Unit)
Figure 8. The Top 3 and 5 Players Market Share by Conjugate Vaccine Revenue in 2019
Figure 9. By Type - South Korea Conjugate Vaccine Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Conjugate Vaccine Market Share, 2015-2020
Figure 11. By Type - South Korea Conjugate Vaccine Market Share, 2020-2026
Figure 12. By Type - South Korea Conjugate Vaccine Price (USD/Unit), 2015-2026
Figure 13. By Application - Conjugate Vaccine Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Conjugate Vaccine Market Share, 2015-2020
Figure 15. By Application - South Korea Conjugate Vaccine Market Share, 2020-2026
Figure 16. By Application -South Korea Conjugate Vaccine Price (USD/Unit), 2015-2026
Figure 17. South Korea Conjugate Vaccine Production Capacity (Million Unit), 2015-2026
Figure 18. South Korea Conjugate Vaccine Actual Output (Million Unit), 2015-2026
Figure 19. South Korea Conjugate Vaccine Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Conjugate Vaccine Export Destination, 2019
Figure 21. The Source of Imports of South Korea Conjugate Vaccine, 2019
Figure 22. PEST Analysis for South Korea Conjugate Vaccine Market in 2020
Figure 23. Conjugate Vaccine Market Opportunities & Trends in South Korea
Figure 24. Conjugate Vaccine Market Drivers in South Korea
Figure 25. Conjugate Vaccine Market Restraints in South Korea
Figure 26. Conjugate Vaccine Industry Value Chain